knowledge -WSS

knowledge

author：fashion 2025-10-02 23:44:59 - browse：3244

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

focus

WSS

Close Medicare's dangerous gaps in addiction treatment coverage

Parkland mass shooting to be reenacted for lawsuit

'Cuddling' is just what the doctor ordered for a 200

Medical schools are missing the mark on artificial intelligence

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Lifetime voting ban for felony convictions struck down in Mississippi

hotspot

knowledge

focus

Drug repurposing or repositioning? The language matters

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Anesthesiologist group: stop taking Ozempic before surgery

Why does health care cost so much? A reading guide

Alkermes shareholders re

Lifetime voting ban for felony convictions struck down in Mississippi

The cancer drug shortage isn’t new — and neither are the solutions

H5N1 bird flu virus started spreading in cows in Texas in December

Apple is now the first public company to be valued at $3 trillion

Cell therapy fails to slow type 1 diabetes, but safety is established

focus

Scientists find bacteria from stomach of ancient iceman

Bird flu in milk supply is likely coming from asymptomatic cows

Health care needs a new profession: neuroimaging counseling

Prosecutors seek bail revocation for FTX founder Sam Bankman

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Exact Sciences stock tumbles despite strong cancer detection sales

focus

focus

focus

hotspot